We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
N4 Pharma Plc | LSE:N4P | London | Ordinary Share | GB00BYW8QM32 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.80 | 0.75 | 0.85 | 0.80 | 0.80 | 0.80 | 6,637 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Drug & Proprietary Stores | 0 | -1.03M | -0.0057 | -1.40 | 1.45M |
Date | Subject | Author | Discuss |
---|---|---|---|
21/10/2020 14:34 | That comeback never gets old haha! | featherby81 | |
21/10/2020 14:32 | But Nuvec still hasn't been in a human yet. The risk will remain high until that happens! The reality is that beloved Nigel has always exaggerated how far this technology was along the path. I have been truly shocked recently with how far it really is from being a reliable technology. | nobbygnome | |
21/10/2020 14:30 | Nobby called the sildenafil trial well, the delay between sublingual and oral was always the riskiest part and most people were investing because it was going into a market that had a need for an improved version. Sadly it failed and the BOD luckily killed it instead of flogging it back to the drawing board. Unfortunately Nobby you (we) don’t have the same red flags as before as this is a totally different product. There’s always risk with everything but as it stands this shouldn’t be written off until it’s been involved in human studies. There’s demand for this type of system and Nuvec does have far superior elements that would seem attractive to a partner but it’s also got a way to go before the real big investors join the ride, they will be paying far more than today’s punt money though. Pay your money, take your chance. It could be wiped out or it could be life changing.. no middle ground with this. | featherby81 | |
21/10/2020 14:23 | Ok if you sold that high well done but I find it hard to believe you hold because anyone even with a small punt would not be negative about the company . | charlie8888 | |
21/10/2020 14:09 | Post 257 from Ch1rp is particularly amusing. He is an erstwhile 'expert' on this thread. He seems to have disappeared now presumably because he lost a fortune. And wasn't hugh a complete and utter plonker....he also lost a fortune! | nobbygnome | |
21/10/2020 14:03 | Here you go from two years ago. It was an education to a few... | nobbygnome | |
21/10/2020 13:52 | I agree with you nobby, making money is what investing is all about. I must say nobby, my small punt must be a lot smaller than your small punt! | barrie16 | |
21/10/2020 13:50 | >> Charlie Go back and look at the thread from a couple of years ago. I did sell out most near the top because having bought on momentum I then did my research and realised it was a complete dog. However, I was left with a small amount because I was too greedy which I did lose money on but was well up overall. It is all documented. The reality is that I have called this correctly all the way down from 30p. I know you will all hate this but just go back and read the evidence! | nobbygnome | |
21/10/2020 13:43 | You're wrong Charlie. Nobby has an uncanny knack of buying at the all time low, and selling at the very top. | hodhasharon | |
21/10/2020 13:29 | I bet nobby is one of the Original investors that brought in at 30 p then sold in panic at 3p . I would be as bitter as him if it had been me , so we should go easy on him . | charlie8888 | |
21/10/2020 12:55 | >> barrie In case you haven't noticed, it's all about making money. I have just done that on a dog of a company like N4P because of the rampers so happy days. | nobbygnome | |
21/10/2020 12:16 | But nobby you said you only took a small punt. Is the small profit worth it??trouble. | barrie16 | |
21/10/2020 12:02 | Happy days but out already. As I said this was a punt not an investment. I remain as wary of this company as ever! | nobbygnome | |
21/10/2020 11:57 | The Lab technician nobbsta has gone quiet after the rise | charlie8888 | |
21/10/2020 11:10 | Mug punterzzz like Nobby finally seeing there's value here | jibba jabber | |
21/10/2020 10:28 | This looks interesting .... Novel Silica Delivery System Enters Final Preclinical Development Stage N4 Pharma Plc recently announced results from the company’s latest research study into its novel silica nanoparticle for cancer treatments and vaccines, Nuvec. The work, which repeated and expanded on a previous pDNA OVA study, has demonstrated that Nuvec is capable of working in vivo when using multiple injections at specific doses. Together with previously acquired data, these results also confirm that Nuvec, under the appropriate conditions, can promote transfection using both DNA and RNA. N4 Pharma will now focus its final preclinical development programs on optimizing the Nuvec loading process in order to increase the consistency of the in vivo performance. Once successful, this will allow the company to move from exploratory collaborations to engage in full licensing discussions. ....... | master rsi | |
21/10/2020 10:23 | Profit taking gone and with large spread signal Buyers are back with a very narrow spread now | master rsi | |
21/10/2020 10:12 | Peaky/Disney/Samsung | hodhasharon | |
21/10/2020 10:11 | Boooom nobby. Let’s hope it holds this time . Some might see it a chance to get out , well those that got spiked last time . | charlie8888 | |
21/10/2020 09:58 | 2 x 250k buys! | jusjusjus | |
21/10/2020 09:45 | on Twitter they're citing the large buys at the end of last 2 days | jusjusjus | |
21/10/2020 09:44 | Should be way higher, so that's where it's going:)))DPL please don't bore us with a ridiculous comment. | ch1rp | |
21/10/2020 09:39 | Good size buys ( meaning above MM size are showing at the ticker, this is doing the rounds on the MMs moving the prices higher at the bid side. | master rsi |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions